v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash $ 4,138 $ 3,331
Accounts receivable - net 11,962 11,888
Contract asset 5,455 5,094
Inventory 480 465
Current assets - related party 16 16
Prepaid expenses and other current assets 2,225 2,449
Total current assets 24,276 23,243
Property and equipment - net 5,438 5,317
Operating lease right-of-use assets 4,107 4,365
Intangible assets - net 23,237 25,074
Goodwill 19,186 19,186
Other assets 641 641
TOTAL ASSETS 76,885 77,826
Current liabilities:    
Accounts payable 5,921 5,798
Accrued compensation 2,765 3,444
Accrued expenses 6,350 5,065
Operating lease liability (current portion) 1,775 1,888
Deferred revenue (current portion) 1,386 1,380
Notes payable (current portion) 167 292
Dividend payable 5,438 5,433
Total current liabilities 23,802 23,300
Notes payable 35 37
Borrowings under line of credit 9,000 10,000
Operating lease liability 2,320 2,516
Deferred revenue 308 256
Total liabilities 35,465 36,109
COMMITMENTS AND CONTINGENCIES (NOTE 7)
SHAREHOLDERS’ EQUITY:    
Preferred stock, $0.001 par value - authorized 7,000,000 shares. Series A, issued and outstanding 4,526,231 shares at March 31, 2024 and December 31, 2023. Series B, issued and outstanding 1,482,792 and 1,468,792 shares at March 31, 2024 and December 31, 2023, respectively 6 6
Common stock, $0.001 par value - authorized 35,000,000 shares. Issued 16,859,291 and 16,620,891 shares at March 31, 2024 and December 31, 2023, respectively. Outstanding 16,118,492 and 15,880,092 shares at March 31, 2024 and December 31, 2023, respectively 17 17
Additional paid-in capital 120,622 120,706
Accumulated deficit (74,722) (74,481)
Accumulated other comprehensive loss (3,841) (3,869)
Less: 740,799 common shares held in treasury, at cost at March 31, 2024 and December 31, 2023 (662) (662)
Total shareholders’ equity 41,420 41,717
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 76,885 $ 77,826

Source